The American Cancer Society estimates that 22,280 new cases and 15,500 deaths from ovarian cancer occurred in the U.S. in 2012. The disease is the leading cause of death from gynecological cancers, as well as the fifth-leading cause of cancer deaths in women. Alicia Algecerias-Schimnich, Ph.D., discusses more about ovarian cancer in the March issue of Clinical Laboratory News, the monthly publication from the American Association for Clinical Chemistry.
Below is a summary of the article, "Ovarian Cancer: A Review of Current Serum Markers and Their Clinical Applications":
The lack of an effective screening test has contributed to ovarian cancer's low survival rate. Although much effort has gone into the search for sensitive and specific tumor markers, few are available today. Laboratory professionals should work closely with clinicians to ensure the available biomarkers are used appropriately to help overcome this deadly cancer.